Sarepta Therapeutics Retained Earnings (Accumulated Deficit) 2010-2025 | SRPT
Sarepta Therapeutics retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $-4.658B, a 5.63% increase year-over-year.
- Sarepta Therapeutics retained earnings (accumulated deficit) for 2024 were $-4.211B, a 5.29% decline from 2023.
- Sarepta Therapeutics retained earnings (accumulated deficit) for 2023 were $-4.446B, a 13.71% increase from 2022.
- Sarepta Therapeutics retained earnings (accumulated deficit) for 2022 were $-3.91B, a 21.94% increase from 2021.